Sen. Jim Banks (R-Ind.) wants the Food and Drug Administration to look into foreign-made active pharmaceutical ingredients he ...

Around 3,500 employees are on the chopping block at the Food and Drug Administration, but they don’t yet know who they are.

The cuts sent shockwaves through the department’s sprawling workforce, prompting a scramble among senior agency officials to ...

Robert F. Kennedy Jr.'s overhaul of federal health agencies will likely impact how Americans get health care, prescription drugs and more.

A small government agency responsible for surveilling the practice of medicine and patient safety is taking a big hit as HHS ...

Some U.S. health regulators who review medical devices and tobacco products for safety and efficacy are struggling to meet ...

The web page comprises questions the FDA received from stakeholders, including industry, trade associations and consumers, ...

Americans pay far more for GLP-1 drugs than citizens in other wealthy nations. If Dr. Marty Makary, the new FDA commissioner, ...

Critics worry that the user fee program creates a conflict of interest between the FDA and pharmaceutical companies.

Larimar Therapeutics, Inc. (Nasdaq: LRMR) has announced significant progress in its nomlabofusp program for Friedreich’s ...

The Senate has confirmed Dr Jay Bhattacharya as the new director of the NIH and Dr Marty Makary as the new commissioner of the FDA.

As the scientific community reels from Trump’s war on science and public health, what is being put in place is a regime of ...